Congress probes celebrity endorsers

Share this article:

Congress is investigating the use of celebrity endorsements in pharmaceutical advertising—starting with a “celebrity doctor,” artificial heart inventor Dr. Robert Jarvik.

In a letter to Pfizer honcho Jeff Kindler, Michigan Democrats John Dingell, chairman of the House Committee on Energy and Commerce, and Bart Stupak, chairman of the House Subcommittee on Oversight and Investigations, announced that they are looking into Pfizer's use of Dr. Jarvik in ads for Lipitor.

“We are concerned that consumers may misinterpret the health claims of a prescription drug promoted in a (DTC) advertisement utilizing a celebrity physician,” Dingell wrote, adding that consumers might also overestimate the qualifications of Dr. Jarvik “given that he may not be a practicing physician with a valid license in any state.”

Dr. Jarvik invented the Jarvik 7, the first successful permanent artificial heart, but is not a practicing physician.

The letter, dated Jan. 7, requested all records pertaining to the campaign and Pfizer's relationship with Dr. Jarvik, including financial records, contractual arrangements, correspondence and scripts for TV and print ads with Jarvik. The committee also requested “any records relating to the veracity of any claims made by Dr. Jarvik” in ads, “including but not limited to his use of Lipitor” and “all records relating to Dr. Jarvik's professional qualifications and why Pfizer chose him as their spokesman for Lipitor.” 

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Headliner: Ipsen head leads continental charge

Headliner: Ipsen head leads continental charge

"When I look at the business, I actually see patients in my mind. I don't see numbers."

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets